TGFB1 and neoplasm: In contrast, in an advanced stage of tumor cells, it acts as tumorigenesis [212]; TGF-β signaling is mediated by two transmembrane receptors, TGF-β type I and II, and the ligand binding leads to SMAD2/3 phosphorylation and activation [213].